Semaglutide impurities des-11-Ser-SMT (Semaglutide Impurities, des-11-Ser-SMT) are impurities that may be produced during the synthesis or degradation of semaglutide (a GLP-1 receptor agonist used to treat type 2 diabetes and obesity). The structural feature of this impurity is the absence of the 11th serine residue (des-11-Ser). As a key analytical object for drug quality control, its content monitoring is of great significance to ensure the safety and efficacy of semaglutide.
Product Overview
Basic Description |
Structure and function: |
Three-letter sequence |
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly |
Single letter sequence |
HAEGETTFSDVYLGQAAKELIAWLVRGRG |
Molecular formula |
C179H261N45O55S |
Molecular weight |
4,081.9 g/mol |
Product Attributes
purity |
>98% |
form |
Lyophilized powder |
Storage conditions |
Store at -20°C/-80°C away from light |